CD4 and coronary artery disorder: Our previous study revealed that JKAP represses the CD4+ T cell from differentiating into Th1 and Th17 cells in vitro and in vivo and is negatively correlated with Th1 and Th17 cells in blood from patients with coronary heart disease (22).